Aprea Therapeutics Announces Interim Results From the Ongoing First-in-human Phase 1 Study of WEE1 Inhibitor APR-1051 in Patients with Advanced Solid Tumors (ACESOT-1051) at the 38th EORTC-NCI-AACR Symposium in Barcelona November 22, 2026
Hair Loss Treatment: A Normal Blood Count Does Not Rule Out Iron Deficiency Hair Loss, and Most Treatment Never Orders the Ferritin Test November 22, 2026
Sagtec Global Limited Announces Additional Share Acquisition by CEO, Reinforcing Confidence in Long-Term Growth Strategy November 22, 2026
Bluum Strengthens Executive Team to Accelerate Innovation and Growth Across K20 Education November 22, 2026
Greenland Mines Applauds Danish Parliament’s Unanimous Approval of Landmark U.S.-Denmark-Greenland Security Agreement November 22, 2026
SKYRESERVE INTRODUCES THE FIRST PLATFORM TO COMPARE AND BOOK PRIVATE CHARTER, FIRST AND BUSINESS CLASS IN ONE PLACE November 22, 2026